These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 15885882
1. DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma. Park HJ, Yu E, Shim YH. Cancer Lett; 2006 Feb 28; 233(2):271-8. PubMed ID: 15885882 [Abstract] [Full Text] [Related]
2. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Oh BK, Kim H, Park HJ, Shim YH, Choi J, Park C, Park YN. Int J Mol Med; 2007 Jul 28; 20(1):65-73. PubMed ID: 17549390 [Abstract] [Full Text] [Related]
3. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Hepatology; 2001 Mar 28; 33(3):561-8. PubMed ID: 11230735 [Abstract] [Full Text] [Related]
4. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H, Hirohashi S. Hepatology; 1999 Mar 28; 29(3):703-9. PubMed ID: 10051471 [Abstract] [Full Text] [Related]
5. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI. Gastroenterology; 2007 Apr 28; 132(4):1476-94. PubMed ID: 17408664 [Abstract] [Full Text] [Related]
6. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM. Mol Carcinog; 2002 Oct 28; 35(2):85-92. PubMed ID: 12325038 [Abstract] [Full Text] [Related]
7. Expression of DNA methyltransferases in multistep hepatocarcinogenesis. Choi MS, Shim YH, Hwa JY, Lee SK, Ro JY, Kim JS, Yu E. Hum Pathol; 2003 Jan 28; 34(1):11-7. PubMed ID: 12605361 [Abstract] [Full Text] [Related]
8. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP. Gynecol Oncol; 2001 Aug 28; 82(2):299-304. PubMed ID: 11531283 [Abstract] [Full Text] [Related]
9. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. Girault I, Tozlu S, Lidereau R, Bièche I. Clin Cancer Res; 2003 Oct 01; 9(12):4415-22. PubMed ID: 14555514 [Abstract] [Full Text] [Related]
10. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG. Exp Mol Pathol; 2010 Dec 01; 89(3):268-75. PubMed ID: 20620135 [Abstract] [Full Text] [Related]
11. Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Yakushiji T, Uzawa K, Shibahara T, Noma H, Tanzawa H. Int J Oncol; 2003 Jun 01; 22(6):1201-7. PubMed ID: 12738984 [Abstract] [Full Text] [Related]
12. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M, Horio Y, Sekido Y, Minna JD, Shimokata K, Hasegawa Y. Oncogene; 2002 Jul 18; 21(31):4822-9. PubMed ID: 12101420 [Abstract] [Full Text] [Related]
13. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, Jiang SW. Gynecol Oncol; 2005 Mar 18; 96(3):601-9. PubMed ID: 15721400 [Abstract] [Full Text] [Related]
14. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Kim H, Kwon YM, Kim JS, Han J, Shim YM, Park J, Kim DH. Cancer; 2006 Sep 01; 107(5):1042-9. PubMed ID: 16888795 [Abstract] [Full Text] [Related]
15. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Proc Natl Acad Sci U S A; 2002 Jul 23; 99(15):10060-5. PubMed ID: 12110732 [Abstract] [Full Text] [Related]
16. Genome-wide hypomethylation in hepatocellular carcinogenesis. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF. Cancer Res; 2001 May 15; 61(10):4238-43. PubMed ID: 11358850 [Abstract] [Full Text] [Related]
17. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. Nat Genet; 2003 Jan 15; 33(1):61-5. PubMed ID: 12496760 [Abstract] [Full Text] [Related]
18. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Hsu LS, Lee HC, Chau GY, Yin PH, Chi CW, Lui WY. Oncol Rep; 2006 Feb 15; 15(2):507-11. PubMed ID: 16391877 [Abstract] [Full Text] [Related]
19. p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Li X, Hui AM, Sun L, Hasegawa K, Torzilli G, Minagawa M, Takayama T, Makuuchi M. Clin Cancer Res; 2004 Nov 15; 10(22):7484-9. PubMed ID: 15569978 [Abstract] [Full Text] [Related]
20. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L. Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889 [Abstract] [Full Text] [Related] Page: [Next] [New Search]